Home
About
Overview
Sharing Data
ORCID
Help
History (30)
Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health.
The role of redox active copper(II) on antioxidant properties of the flavonoid baicalein: DNA protection under Cu(II)-Fenton reaction and Cu(II)-ascorbate system conditions.
Medication effects on periurethral sensation and urethral sphincter activity.
Ocular signs predictive of tubercular uveitis.
Immunogenicity of infliximab in Crohn's disease.
See All 30 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Immunogenicity of infliximab in Crohn's disease.
Immunogenicity of infliximab in Crohn's disease. N Engl J Med. 2003 May 22; 348(21):2155-6; author reply 2155-6.
View in:
PubMed
subject areas
Adjuvants, Immunologic
Antibodies
Antibodies, Monoclonal
Crohn Disease
Drug Administration Schedule
Drug Therapy, Combination
Gastrointestinal Agents
Humans
Infliximab
Tumor Necrosis Factor-alpha
authors with profiles
Stephen B. Hanauer